• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶在青光眼患者房水调节中的作用。

The role of matrix metalloproteinases in the modulation of aqueous humor in glaucoma patients.

作者信息

Teodor Cerbulescu, Ramona Barac Ileana, Ovidiu Boruga, Casiana Sălăvăţ Mădălina, Laurenţiu Leuştean, Daciana Duncă Ştefan, Andrei Calancea, Diana Barac Andreea

机构信息

"Victor Babeş" University of Medicine and Pharmacy, Timişoara, Romania.

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Rom J Ophthalmol. 2025 Apr-Jun;69(2):208-211. doi: 10.22336/rjo.2025.33.

DOI:10.22336/rjo.2025.33
PMID:40698094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277996/
Abstract

Matrix metalloproteinases are crucial proteolytic enzymes involved in the degradation and remodeling of the extracellular matrix within the ocular structures. Their expression and activity significantly influence aqueous humor dynamics and intraocular pressure in patients with glaucoma. Elevated intraocular pressure, a significant risk factor for glaucoma, is often associated with disturbed aqueous humor outflow. This review summarizes current findings on the role of matrix metalloproteinases in modulating aqueous humor and their potential as therapeutic targets in the treatment of glaucoma.

摘要

基质金属蛋白酶是关键的蛋白水解酶,参与眼部结构中细胞外基质的降解和重塑。它们的表达和活性对青光眼患者的房水动力学和眼压有显著影响。眼压升高是青光眼的一个重要危险因素,常与房水流出受阻有关。本综述总结了关于基质金属蛋白酶在调节房水中的作用及其作为青光眼治疗靶点的潜力的当前研究结果。

相似文献

1
The role of matrix metalloproteinases in the modulation of aqueous humor in glaucoma patients.基质金属蛋白酶在青光眼患者房水调节中的作用。
Rom J Ophthalmol. 2025 Apr-Jun;69(2):208-211. doi: 10.22336/rjo.2025.33.
2
Minimally Invasive Glaucoma Surgery Procedure in the Human Eye. A Fluid Structure Interaction Study.人眼微创青光眼手术过程。流体结构相互作用研究。
Int J Numer Method Biomed Eng. 2025 Jul;41(7):e70062. doi: 10.1002/cnm.70062.
3
[Modeling and finite element analysis of human trabecular meshwork outflow pathways].[人小梁网流出途径的建模与有限元分析]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2025 Jun 25;42(3):585-591. doi: 10.7507/1001-5515.202407037.
4
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.青光眼患者视网膜神经节细胞凋亡与眼压及眼压诱导的细胞外基质效应有关。
Invest Ophthalmol Vis Sci. 2005 Jan;46(1):175-82. doi: 10.1167/iovs.04-0832.
5
A quantum-inspired neural fuzzy sliding mode control framework for fractional-order modeling of intraocular pressure regulation and optic nerve damage in glaucoma.一种用于青光眼眼压调节和视神经损伤分数阶建模的量子启发式神经模糊滑模控制框架。
Sci Rep. 2025 Jul 2;15(1):23438. doi: 10.1038/s41598-025-99501-y.
6
TGFβ2 alters segmental outflow and ECM ultrastructure in the trabecular meshwork.转化生长因子β2改变小梁网中的节段性房水流出及细胞外基质超微结构。
Exp Eye Res. 2025 Jun;255:110377. doi: 10.1016/j.exer.2025.110377. Epub 2025 Apr 10.
7
Aqueous Angiography-Guided Bent Ab Interno Needle Goniectomy in High Versus Low Aqueous Humor Outflow Regions in Primary Open Angle Glaucoma: A Pilot Randomized Controlled Trial.原发性开角型青光眼高、低房水流出区域水造影引导下经结膜内置弯针睫状体切除术:一项初步随机对照试验
J Glaucoma. 2025 Apr 1;34(4):317-324. doi: 10.1097/IJG.0000000000002537. Epub 2025 Jan 16.
8
Measurement of postmortem outflow facility using iPerfusion.使用 iPerfusion 测量死后流出道功能。
Exp Eye Res. 2022 Jul;220:109103. doi: 10.1016/j.exer.2022.109103. Epub 2022 May 5.
9
Iridotomy to slow progression of visual field loss in angle-closure glaucoma.虹膜切开术减缓闭角型青光眼视野丧失的进展。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD012270. doi: 10.1002/14651858.CD012270.pub3.
10
Cyclodestructive procedures for non-refractory glaucoma.非难治性青光眼的睫状体破坏手术
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD009313. doi: 10.1002/14651858.CD009313.pub2.

本文引用的文献

1
The impact of matrix metalloproteinases and their tissue inhibitors in patients with chronic glaucoma - a literature review.基质金属蛋白酶及其组织抑制剂在慢性青光眼患者中的作用——文献综述
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):557-565. doi: 10.47162/RJME.65.4.01.
2
Tear matrix metalloproteinase-9 levels may help to follow a ocular surface injury in lagophthalmic eyes.眼裂闭合不全患者的眼表损伤可能与泪液中基质金属蛋白酶-9 水平有关。
PLoS One. 2022 Sep 9;17(9):e0274173. doi: 10.1371/journal.pone.0274173. eCollection 2022.
3
Smoking Cessation May Reduce Risk of Visual Field Progression in Heavy Smokers.戒烟可能降低重度吸烟者视野进展的风险。
J Glaucoma. 2022 Oct 1;31(10):796-803. doi: 10.1097/IJG.0000000000002092. Epub 2022 Aug 2.
4
Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment.负载抗高血压药物的新型渗透保护型二油酰磷脂酰胆碱-二肉豆蔻酰磷脂酰胆碱脂质体作为青光眼治疗的潜在策略
Pharmaceutics. 2022 Jul 4;14(7):1405. doi: 10.3390/pharmaceutics14071405.
5
The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma.正在研发的降低高眼压症和青光眼患者眼压的最新药物。
J Exp Pharmacol. 2020 Nov 20;12:539-548. doi: 10.2147/JEP.S281187. eCollection 2020.
6
Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease.羊膜细胞因子提取物治疗干眼症的安全性和有效性。
Clin Ophthalmol. 2019 May 27;13:887-894. doi: 10.2147/OPTH.S203510. eCollection 2019.
7
MMPs in the trabecular meshwork: promising targets for future glaucoma therapies?小梁网中的 MMPs:未来青光眼治疗的有希望的靶点?
Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7756-63. doi: 10.1167/iovs.13-13088.